Post-SARS-CoV-2 vaccination venous sinus thrombosis: a literature review of 308 cases
Open Access
- 20 December 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 57 (1), 1-6
- https://doi.org/10.1186/s41983-021-00431-z
Abstract
There is accumulating evidence that SARS-CoV-2 vaccinations can be complicated by venous sinus thrombosis (VST). This review aimed at summarising and discussing previous and recent advances regarding the diagnosis, pathogenesis, treatment, and outcome of post-SARS-CoV-2 vaccination VST. At least 308 patients with post-SARS-CoV-2 vaccination VST have been reported as per the end of July 2021. Ages among these 308 patients ranged between 22 and 81 years, 69 were male and 197 were female. Post-SARS-CoV-2 vaccination VST most commonly occurred with the ChAdOx1-S vaccine followed by the BNT126b2 vaccine. In the vast majority of cases, VST occurred after the first dose. Only in six patients did VST occur after the second dose. Latency between vaccination and onset of VST ranged between 0 and 24 days. Regarding treatment, most patients received heparin followed by oral anticoagulants. Seven patients received IVIGs and six patients received steroids because of concomitant vaccine-induced immune thrombotic thrombocytopenia. Complete recovery was reported in 5 patients. Partial recovery was reported in 9 patients. Eight patients were alive or discharged. Sixty-two patients died. The outcome was not specified in the remainder. In conclusion, SARS-CoV-2 vaccinations can be complicated by VST. There is female preponderance and the outcome is frequently poor.Keywords
This publication has 42 references indexed in Scilit:
- Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK casesBrain, Behavior, and Immunity, 2021
- US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021JAMA, 2021
- Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19Critical Care, 2021
- Thrombocytopenia and Intracranial Venous Sinus Thrombosis after “COVID-19 Vaccine AstraZeneca” ExposureJournal of Clinical Medicine, 2021
- A Rare Case of Cerebral Venous Thrombosis and Disseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine AdministrationJournal of Personalized Medicine, 2021
- Cerebral Venous Sinus Thrombosis in COVID-19 Infection: A Case Series and Review of The LiteratureJournal of Stroke and Cerebrovascular Diseases, 2020
- Cerebral Venous Sinus Thrombosis in the COVID-19 PandemicJournal of Neuro-Ophthalmology, 2020
- Venous cerebral thrombosis in COVID-19 patientJournal of the Neurological Sciences, 2020
- Links Between Complement Activation and ThrombosisBlood, 2019